DK3390A - Monoklonalt antistof, som er specifikt for adhaesionsfunktionsdomaenet af et fagocytcelleoverfladeprotein - Google Patents

Monoklonalt antistof, som er specifikt for adhaesionsfunktionsdomaenet af et fagocytcelleoverfladeprotein Download PDF

Info

Publication number
DK3390A
DK3390A DK003390A DK3390A DK3390A DK 3390 A DK3390 A DK 3390A DK 003390 A DK003390 A DK 003390A DK 3390 A DK3390 A DK 3390A DK 3390 A DK3390 A DK 3390A
Authority
DK
Denmark
Prior art keywords
monoclonal antibody
phagocycle
cell surface
antibody specific
surface protein
Prior art date
Application number
DK003390A
Other languages
English (en)
Other versions
DK3390D0 (da
Inventor
Stuart F Schlossman
James D Griffin
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of DK3390D0 publication Critical patent/DK3390D0/da
Publication of DK3390A publication Critical patent/DK3390A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK003390A 1987-07-06 1990-01-05 Monoklonalt antistof, som er specifikt for adhaesionsfunktionsdomaenet af et fagocytcelleoverfladeprotein DK3390A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7025787A 1987-07-06 1987-07-06
US07/165,024 US5019648A (en) 1987-07-06 1988-03-07 Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein
PCT/US1988/001414 WO1989000190A1 (en) 1987-07-06 1988-05-02 Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein

Publications (2)

Publication Number Publication Date
DK3390D0 DK3390D0 (da) 1990-01-05
DK3390A true DK3390A (da) 1990-03-05

Family

ID=26750961

Family Applications (1)

Application Number Title Priority Date Filing Date
DK003390A DK3390A (da) 1987-07-06 1990-01-05 Monoklonalt antistof, som er specifikt for adhaesionsfunktionsdomaenet af et fagocytcelleoverfladeprotein

Country Status (15)

Country Link
US (1) US5019648A (da)
EP (1) EP0357672B1 (da)
JP (1) JPH03501560A (da)
KR (1) KR960009013B1 (da)
CN (1) CN1028114C (da)
AT (1) ATE121130T1 (da)
AU (1) AU616182B2 (da)
CA (1) CA1340015C (da)
DE (1) DE3853588T2 (da)
DK (1) DK3390A (da)
ES (1) ES2013338A6 (da)
IE (1) IE61392B1 (da)
IL (1) IL86676A (da)
MX (1) MX9203245A (da)
WO (1) WO1989000190A1 (da)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219997A (en) * 1987-07-06 1993-06-15 Dana-Farber Cancer Institute Monoclonal antibody which inhibits the adhesion functions of the β integrin, CR3
US5019648A (en) * 1987-07-06 1991-05-28 Dana-Farber Cancer Institute Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein
AU625454B2 (en) * 1988-03-31 1992-07-09 Biomedical Systems Limited Therapeutic murine monoclonal antibody
US5272263A (en) * 1989-04-28 1993-12-21 Biogen, Inc. DNA sequences encoding vascular cell adhesion molecules (VCAMS)
US5217870A (en) * 1989-04-28 1993-06-08 Biogen, Inc. Monoclonal antibodies against CDX
GB9115364D0 (en) * 1991-07-16 1991-08-28 Wellcome Found Antibody
CA2135390A1 (en) * 1992-05-11 1993-11-25 Matthew Moyle Novel neutrophil inhibitors
US5708141A (en) * 1992-05-11 1998-01-13 Corvas International, Inc. Neutrophil inhibitors
EP1340811A3 (en) * 1992-05-22 2003-11-19 Montana State University Antibodies with specificity for multiple adhesion molecules
AU674556B2 (en) * 1992-10-09 1997-01-02 Center For Blood Research, Inc., The A subpopulation of MAC-1 molecules which mediate neutrophil adhesion to ICAM-1 and fibrinogen
US7083979B1 (en) * 1994-03-25 2006-08-01 Indiana University Foundation Methods for enhanced retroviral-mediated gene transfer
US5656441A (en) * 1994-04-19 1997-08-12 Trustees Of Boston University Methods for determining cellular adhesion
US5834889A (en) * 1995-09-22 1998-11-10 Gl Displays, Inc. Cold cathode fluorescent display
US6001356A (en) * 1995-09-29 1999-12-14 Rush-Presbyterian-St. Luke's Medical Center Method of inhibiting tissue destruction in autoimmune disease using anti-CD44 antibodies
DE19739879A1 (de) * 1996-09-19 1998-03-26 Zeiss Carl Fa Kippvorrichtung
JP2003527439A (ja) 2000-03-17 2003-09-16 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 抗ｃｄ１８抗体と抗ｃｃｒ２抗体の混合物を用いる狭窄および再狭窄を抑制する方法
US8914114B2 (en) 2000-05-23 2014-12-16 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
JP2005522457A (ja) * 2002-02-26 2005-07-28 ノース ショア−ロング アイランド ジューイッシュ リサーチ インスティチュート 脳ムスカリン性レセプターの刺激による炎症性サイトカイン産生の阻害
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
JP2007530586A (ja) 2004-03-25 2007-11-01 ザ ファインスタイン インスティテュート フォー メディカル リサーチ 神経性止血法
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
CN101124012B (zh) 2004-12-27 2012-09-05 范因斯坦医学研究院 通过电刺激迷走神经治疗炎症性疾病的装置
US8391970B2 (en) * 2007-08-27 2013-03-05 The Feinstein Institute For Medical Research Devices and methods for inhibiting granulocyte activation by neural stimulation
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
WO2009146030A1 (en) * 2008-03-31 2009-12-03 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation of t-cell activity
US8412338B2 (en) 2008-11-18 2013-04-02 Setpoint Medical Corporation Devices and methods for optimizing electrode placement for anti-inflamatory stimulation
US8996116B2 (en) 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US8788034B2 (en) 2011-05-09 2014-07-22 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
CN102573986B (zh) 2009-06-09 2016-01-20 赛博恩特医疗器械公司 用于无导线刺激器的具有袋部的神经封套
WO2011028763A2 (en) * 2009-09-01 2011-03-10 Setpoint Medical Corporation Prescription pad for treatment of inflammatory disorders
US11051744B2 (en) 2009-11-17 2021-07-06 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
US9833621B2 (en) 2011-09-23 2017-12-05 Setpoint Medical Corporation Modulation of sirtuins by vagus nerve stimulation
CN102821814B (zh) 2009-12-23 2015-07-15 赛博恩特医疗器械公司 用于治疗慢性炎症的神经刺激设备和系统
US12172017B2 (en) 2011-05-09 2024-12-24 Setpoint Medical Corporation Vagus nerve stimulation to treat neurodegenerative disorders
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
WO2016126807A1 (en) 2015-02-03 2016-08-11 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
EP3405107B1 (en) 2016-01-20 2023-04-12 Setpoint Medical Corporation Control of vagal stimulation
EP3405255B1 (en) 2016-01-20 2025-12-31 Setpoint Medical Corporation IMPLANTABLE MICROSTIMULATORS AND INDUCTION CHARGING SYSTEMS
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
EP3554257B1 (en) 2016-12-15 2023-07-12 Société des Produits Nestlé S.A. Compositions and methods that modulate white blood cells or neutrophils in a companion animal
WO2019036470A1 (en) 2017-08-14 2019-02-21 Setpoint Medical Corporation TESTING TEST FOR STIMULATION OF NERVE WAVE
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
AU2020272128B9 (en) 2019-04-12 2025-11-20 Setpoint Medical Corporation Vagus nerve stimulation to treat neurodegenerative disorders
JP2023512447A (ja) 2020-01-13 2023-03-27 ザ ファインスタイン インスティチューツ フォー メディカル リサーチ 脾臓への高密度集束超音波刺激による出血及び出血性疾患の治療
WO2021236977A1 (en) 2020-05-21 2021-11-25 The Feinstein Institutes For Medical Research Systems and methods for vagus nerve stimulation
WO2022245878A1 (en) 2021-05-17 2022-11-24 Setpoint Medical Corporation Neurostimulation parameter authentication and expiration system for neurostimulation
US20250229086A1 (en) 2022-01-20 2025-07-17 Setpoint Medical Corporation Treatment of inflammatory disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935234A (en) * 1987-06-11 1990-06-19 Dana-Farber Cancer Institute Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
US4840793A (en) * 1987-06-11 1989-06-20 Dana-Farber Cancer Institute Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
US5019648A (en) * 1987-07-06 1991-05-28 Dana-Farber Cancer Institute Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein

Also Published As

Publication number Publication date
ES2013338A6 (es) 1990-05-01
AU1721888A (en) 1989-01-30
DE3853588D1 (de) 1995-05-18
EP0357672A4 (en) 1990-06-05
US5019648A (en) 1991-05-28
JPH03501560A (ja) 1991-04-11
IE61392B1 (en) 1994-11-02
MX9203245A (es) 1992-07-01
ATE121130T1 (de) 1995-04-15
CN1030611A (zh) 1989-01-25
WO1989000190A1 (en) 1989-01-12
AU616182B2 (en) 1991-10-24
CA1340015C (en) 1998-08-25
KR890701734A (ko) 1989-12-21
DE3853588T2 (de) 1995-11-23
EP0357672A1 (en) 1990-03-14
IE881357L (en) 1989-01-06
KR960009013B1 (ko) 1996-07-10
IL86676A (en) 1992-06-21
IL86676A0 (en) 1988-11-30
DK3390D0 (da) 1990-01-05
EP0357672B1 (en) 1995-04-12
CN1028114C (zh) 1995-04-05

Similar Documents

Publication Publication Date Title
DK3390D0 (da) Monoklonalt antistof, som er specifikt for adhaesionsfunktionsdomaenet af et fagocytcelleoverfladeprotein
AU3615384A (en) Method of detecting immiune complexes in serium
ES2045216T3 (es) Inmunoensayo y derivados polimeros de igg para la compensacion de factores de perturbacion en el inmunoensayo.
ATE67313T1 (de) Nachweis von menschlichem cytomegalovirusspezifischem igm.
KR890015714A (ko) 폐암의 조기 검출 방법
NO163920C (no) Fremgangsmaate for bestemmelse av pivka-ii i fysiologiske proever.
KR960014336A (ko) 사람 글리센틴에 대한 모노클로날 항체, 이러한 항체를 생성하기 위한 하이브리도마 및 상기 항체를 사용한 사람 글리센틴의 검정방법
EP0335134A3 (en) Mouse monoclonal antibody to human immunodeficiency virus gp41 protein
NO179107C (no) Monoklonalt antistoff for selektiv immunologisk bestemmelse av intakt prokollagen-peptid (type III) og prokollagen (type III) i kroppsvæsker, hybridom-cellelinje, anvendelse av antistoffene og diagnostiske sett
ES8504257A1 (es) Un metodo para determinar antigenos estreptococales en una muestra clinica
EP0271810A3 (en) Immunological determination of free human protein s and c4bp-protein s complex
ES2131279T3 (es) Inmunoensayo de tipo sandwich para n-peptido.
ATE80740T1 (de) Immunassay-verfahren.
ES8401261A1 (es) Soportes de materia plastica revestidos de un segundo anticuerpo.
FI882019A0 (fi) Monoklonaalisia vasta-aineita intaktin prokollageenipeptidin (tyyppi III) ja prokollageenin (tyyppi III) selektiivistä, immunologista määritystä varten kehonnesteistä
KR850008620A (ko) Atl 바이러스 항체의 측정방법 및 시약
EP0248147A3 (en) Method of determining the presence of cancer cells
ES8802545A1 (es) Un metodo para determinar prolil 4-hidroxilasa humana por inmunoensayo enzimatico o radioinmunoensayo
ES546338A0 (es) Procedimiento para la determinacion de una sustancia capaz de fijarse inmunologicamente
NO873154D0 (no) Spesifikke monoklonale antistoffer mot overflatereseptor for ige og hybridcellelinjer som produserer disse antistoffer og anvendelse derav.
ES2019573T3 (es) Inmunoensayo para la deteccion de alfa-haloacetamidas.
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
WO1990008956A1 (en) Detection of human tissue factor activator
IE882250L (en) Monoclonal antibodies and methods for diagnosis of Phytophthora infection
EP0339632A3 (en) Method of assaying human cancer antigens

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment